Dr. Abrams is a professor of epidemiology and pediatrics at Columbia University with over 30 years of experience in treatment of HIV infection in pregnant women, children and their families. As the senior director for research at ICAP, she leads ICAP’s large research agenda and is responsible for the development of technical assistance, drug access, pediatric and perinatal prevention initiatives for ICAP programs in sub-Saharan Africa and Asia. Dr. Abrams served three consecutive terms as Chair of the IMPAACT HIV treatment scientific committee and currently guides the network scientific agenda as a member of the Senior Leadership Group. She chaired the WHO consolidated guidelines for the use of antiretroviral drugs since 2015, introducing universal treatment, antiretrovirals for prevention and optimized ARV regimens with dolutegravir. She is also co-chair of the WHO Pediatric Antiretroviral Working Group and is actively involved in the development of policies and protocols for the study of antiretrovirals in children, adolescents and pregnant and lactating women. Dr. Abrams’ research interests have focused on maternal health, mother-to-child HIV transmission, the natural history of pediatric HIV, and optimizing antiretroviral therapy for infants, children, adolescents and pregnant women and breastfeeding women.